来自干细胞的外体微RNA:糖尿病病的潜在疗法
Han Wang1, Jiajia Wang2, Tiejun Liu2
1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130021, China.
概括
来自干细胞的外基因组显示出治疗糖尿病病 (DKD) 的前景. 这些外体,特别是外体微RNA,保护细胞,并为DKD提供一种新的治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 糖尿病病 (DKD) 是一种常见的糖尿病并发症,也是末期病的主要原因.
- 目前的DKD疗法不足,需要开发新的治疗策略.
- 干细胞衍生的外生体正在成为一个有前途的治疗途径,因为它们的再生潜力.
研究的目的:
- 审查干细胞衍生的外体的治疗潜力,专注于外体微RNA,用于治疗糖尿病病.
- 探索这些外体对关键脏细胞类型的保护作用,这些细胞类型参与了DKD病原体的产生.
主要方法:
- 关于研究干细胞衍生外体和它们在糖尿病病中的作用的文献综述.
- 在DKD模型中分析了对外体微RNA对介质细胞,细胞和管状上皮细胞的影响的研究.
主要成果:
- 来自干细胞的外体,特别是它们的microRNA载荷,对介质细胞,细胞和管状上皮细胞表现出保护作用.
- 这些外体调节涉及糖尿病病理生理学的关键途径.
结论:
- 来自干细胞的外体细胞代表了糖尿病病的潜在无细胞治疗策略.
- 进一步的研究应侧重于利用这些外体作为治疗剂,考虑到它们的安全性和缺乏潜在致癌性.
更多相关视频
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
6.1K
07:01A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
1.5K
相关概念视频
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
